EHCNYSEServices-HospitalsFiscal year ends December 31
Encompass Health Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$121.71−6.16 (-4.82%)
Close on Oct 19, 2026
- Market cap
- $12.17B
- P/E (TTM)
- 19.8
- Dividend yield
- 0.59%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
97.0%
96M of 99M shares
Institutional holders
597
66 new, 41 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 18 sales
Net sold $47.79M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 9,125,779 | 9.10% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 5,233,622 | 5.26% | 13G (passive) | Mar 31, 2026 |
| T. Rowe Price Associates, Inc. | 5,056,225 | 5.10% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,484,385 | 10.63% | $1.06B | −284,328 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 5,055,801 | 5.12% | $511.04K | +455,252 | 0.05% |
| Vanguard Portfolio Management LLC | 4,924,664 | 4.99% | $497.79M | −34,881 | 0.02% |
| Vanguard Capital Management LLC | 4,475,896 | 4.54% | $452.42M | +9,659 | 0.01% |
| Wellington Management Group Llp | 3,278,739 | 3.32% | $331.41M | −570,116 | 0.06% |
| State Street Corp | 3,185,798 | 3.23% | $322.02M | +40,824 | 0.01% |
| Citadel Advisors LLC | 2,563,104 | 2.60% | $259.08M | +2,051,217 | 0.03% |
| Alliancebernstein L.P. | 2,471,751 | 2.51% | $239.09M | −149,494 | 0.08% |
| Fuller & Thaler Asset Management, Inc. | 2,460,657 | 2.49% | $248.72M | +230,678 | 0.68% |
| Two Sigma Investments, LP | 2,267,668 | 2.30% | $229.22M | +45,567 | 0.17% |
| Geode Capital Management, LLC | 1,890,743 | 1.92% | $191.16M | −7,924 | 0.01% |
| Dimensional Fund Advisors LP | 1,743,028 | 1.77% | $176.19M | +68,244 | 0.03% |
| Goldman Sachs Group Inc | 1,550,797 | 1.57% | $156.75M | −254,924 | 0.01% |
| Invesco Ltd. | 1,161,108 | 1.18% | $117.36M | −2,224,997 | 0.01% |
| Arrowstreet Capital, Limited Partnership | 1,156,930 | 1.17% | $116.94M | −25,644 | 0.05% |
| Norges Bank | 1,154,864 | 1.17% | $116.73M | New | 0.01% |
| William Blair Investment Management, LLC | 1,151,085 | 1.17% | $116.35M | +347,934 | 0.35% |
| Morgan Stanley | 1,146,873 | 1.16% | $115.93M | +249,891 | 0.01% |
| JPMorgan Chase & Co | 1,133,561 | 1.15% | $114.84M | −97,910 | 0.01% |
| Raymond James Financial Inc | 1,064,233 | 1.08% | $107.57M | −2,773 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 597 | 96M | 97.0% | 66 / 225 | 223 / 41 | 11M | 12M |
| Q1 2026 | 580 | 96M | 97.7% | 77 / 231 | 197 / 83 | 21M | 17M |
| Q4 2025 | 594 | 102M | 100.0% | 83 / 176 | 257 / 78 | 17M | 10M |
| Q3 2025 | 604 | 95M | 96.4% | 55 / 239 | 230 / 50 | 10M | 10M |
| Q2 2025 | 607 | 95M | 96.3% | 113 / 206 | 219 / 37 | 8M | 10M |
| Q1 2025 | 537 | 97M | 98.0% | 60 / 202 | 194 / 60 | 7M | 6M |
| Q4 2024 | 544 | 96M | 97.1% | 98 / 208 | 163 / 31 | 11M | 12M |
| Q3 2024 | 483 | 98M | 99.0% | 50 / 171 | 198 / 39 | 18M | 9M |
| Q2 2024 | 478 | 98M | 99.3% | 74 / 173 | 166 / 29 | 7M | 9M |
| Q1 2024 | 436 | 100M | 100.0% | 60 / 155 | 150 / 57 | 8M | 9M |
| Q4 2023 | 435 | 101M | 100.0% | 63 / 147 | 155 / 35 | 13M | 6M |
| Q3 2023 | 413 | 94M | 95.1% | 57 / 132 | 157 / 29 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of EHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3,394,861 | 3.44% | $343.15M | 0.28% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3,150,844 | 3.19% | $318.49M | 0.01% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 2,347,546 | 2.38% | $237.29M | 1.87% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,275,892 | 2.31% | $230.05M | 0.12% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 1,441,139 | 1.46% | $145.67M | 0.21% | Jun 30, 2026 |
| Vanguard Health Care Fund | 1,252,498 | 1.27% | $139.11M | 0.36% | Jul 31, 2026 |
| T. Rowe Price U.S. Large-Cap Core Fund, Inc. | 1,160,103 | 1.18% | $117.26M | 0.65% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,137,424 | 1.15% | $114.97M | 0.12% | Jun 30, 2026 |
| Vanguard Explorer Fund | 1,034,944 | 1.05% | $114.95M | 0.52% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 848,027 | 0.86% | $85.72M | 0.09% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 593,485 | 0.60% | $59.99M | 0.53% | Jun 30, 2026 |
| Small Cap Growth Fund | 522,726 | 0.53% | $58.06M | 1.04% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 518,122 | 0.53% | $54.84M | 0.13% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 502,111 | 0.51% | $50.75M | 0.28% | Jun 30, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | 483,146 | 0.49% | $48.84M | 0.50% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mark J. Tarr | President & CEO, Director | 267,814 | 0.27% | Aug 11, 2026 |
| John Patrick Darby | EVP, Gen Counsel & Secretary | 79,899 | 0.08% | Sep 1, 2026 |
| Andrew L. Price | Chief Accounting Officer | 69,483 | 0.07% | Sep 1, 2026 |
| Douglas E. Coltharp | EVP & Chief Financial Officer | 241,368 | 0.24% | Aug 11, 2026 |
| Patrick William Tuer | EVP, Chief Operating Officer | 24,755 | 0.03% | May 12, 2026 |
| Edmund Fay | Sr. Vice Pres. and Treasurer | 89,325 | 0.09% | Mar 10, 2026 |
| Elissa Joy Charbonneau | Chief Medical Officer | 17,644 | 0.02% | Mar 3, 2026 |
| Edward M. Christie III | Director | 9,345 | 0.01% | Jul 16, 2026 |
| Joan E. Herman | Director | 49,643 | 0.05% | Jul 16, 2026 |
| Greg D. Carmichael | Director | 20,349 | 0.02% | Jul 16, 2026 |
| Leslye G. Katz | Director | 49,643 | 0.05% | Jul 16, 2026 |
| Nancy M. Schlichting | Director | 22,972 | 0.02% | Jul 16, 2026 |
| Cain A. Hayes | Director | 2,096 | 0.00% | Jul 16, 2026 |
| Kevin J. O'Connor | Director | 11,582 | 0.01% | Jul 16, 2026 |
| Christopher R. Reidy | Director | 17,777 | 0.02% | Jul 16, 2026 |
| Terrance Williams | Director | 16,859 | 0.02% | Jul 16, 2026 |
| Patricia Anne Maryland | Director | 14,764 | 0.01% | Jul 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Andrew L. Price Chief Accounting Officer | Aug 31, 2026 | Sale | −5,211 | $120.93 | $630.17K | 69,483 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Aug 31, 2026 | Option exercise | +4,858 | $35.06 | $170.32K | 79,899 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Aug 31, 2026 | Sale | −4,858 | $121.09 | $588.26K | 75,041 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Aug 10, 2026 | Sale | −8,906 | $125.95 | $1.12M | 75,041 |
| Mark J. Tarr President & CEO, Director | Aug 10, 2026 | Sale | −1,579 | $126.06 | $199.05K | 267,814 |
| Mark J. Tarr President & CEO, Director | Aug 10, 2026 | Sale | −171,569 | $125.46 | $21.53M | 269,393 |
| Douglas E. Coltharp EVP & Chief Financial Officer | Aug 10, 2026 | Sale | −18,869 | $125.38 | $2.37M | 50,508 |
| Edward M. Christie III Director | Jul 16, 2026 | Award | +248 | $112.43 | $27.88K | 9,345 |
| Christopher R. Reidy Director | Jul 16, 2026 | Award | +319 | $112.40 | $35.86K | 17,777 |
| Greg D. Carmichael Director | Jul 15, 2026 | Award | +29 | – | – | 20,349 |
| Edward M. Christie III Director | Jul 15, 2026 | Award | +11 | – | – | 9,097 |
| Terrance Williams Director | Jul 15, 2026 | Award | +29 | – | – | 16,859 |
| Christopher R. Reidy Director | Jul 15, 2026 | Award | +21 | – | – | 17,458 |
| Kevin J. O'Connor Director | Jul 15, 2026 | Award | +19 | – | – | 11,582 |
| Joan E. Herman Director | Jul 15, 2026 | Award | +85 | – | – | 49,643 |
| Cain A. Hayes Director | Jul 15, 2026 | Award | +4 | – | – | 2,096 |
| Nancy M. Schlichting Director | Jul 15, 2026 | Award | +40 | – | – | 22,972 |
| Leslye G. Katz Director | Jul 15, 2026 | Award | +85 | – | – | 49,643 |
| Douglas E. Coltharp EVP & Chief Financial Officer | May 15, 2026 | Option exercise | +27,694 | $32.94 | $912.24K | 97,071 |
| Douglas E. Coltharp EVP & Chief Financial Officer | May 15, 2026 | Sale | −27,693 | $106.83 | $2.96M | 69,378 |
| Douglas E. Coltharp EVP & Chief Financial Officer | May 15, 2026 | Sale | −1 | $107.28 | $107 | 69,377 |
| Patrick William Tuer EVP, Chief Operating Officer | May 11, 2026 | Sale | −682 | $104.56 | $71.31K | 24,755 |
| Nancy M. Schlichting Director | May 7, 2026 | Award | +1,634 | – | – | 22,932 |
| Terrance Williams Director | May 7, 2026 | Award | +1,634 | – | – | 16,830 |
| Greg D. Carmichael Director | May 7, 2026 | Award | +1,634 | – | – | 20,320 |
| Edward M. Christie III Director | May 7, 2026 | Award | +1,634 | – | – | 9,086 |
| Leslye G. Katz Director | May 7, 2026 | Award | +1,634 | – | – | 49,558 |
| Christopher R. Reidy Director | May 7, 2026 | Award | +1,634 | – | – | 17,437 |
| Kevin J. O'Connor Director | May 7, 2026 | Award | +1,634 | – | – | 11,563 |
| Cain A. Hayes Director | May 7, 2026 | Award | +1,634 | – | – | 2,092 |
| Joan E. Herman Director | May 7, 2026 | Award | +1,634 | – | – | 49,558 |
| Edward M. Christie III Director | Apr 16, 2026 | Award | +261 | $106.17 | $27.71K | 7,452 |
| Christopher R. Reidy Director | Apr 16, 2026 | Award | +334 | $106.48 | $35.56K | 15,803 |
| Nancy M. Schlichting Director | Apr 15, 2026 | Award | +39 | – | – | 21,298 |
| Joan E. Herman Director | Apr 15, 2026 | Award | +85 | – | – | 47,924 |
| Leslye G. Katz Director | Apr 15, 2026 | Award | +85 | – | – | 47,924 |
| Edward M. Christie III Director | Apr 15, 2026 | Award | +9 | – | – | 7,191 |
| Christopher R. Reidy Director | Apr 15, 2026 | Award | +19 | – | – | 15,469 |
| Terrance Williams Director | Apr 15, 2026 | Award | +27 | – | – | 15,196 |
| Kevin J. O'Connor Director | Apr 15, 2026 | Award | +17 | – | – | 9,929 |
| Greg D. Carmichael Director | Apr 15, 2026 | Award | +27 | – | – | 18,686 |
| Cain A. Hayes Director | Apr 15, 2026 | Award | +1 | – | – | 458 |
| Edmund Fay Sr. Vice Pres. and Treasurer | Mar 9, 2026 | Sale | −11,937 | $107.00 | $1.28M | 89,325 |
| Edmund Fay Sr. Vice Pres. and Treasurer | Mar 9, 2026 | Gift | −3,000 | – | – | 86,325 |
| Elissa Joy Charbonneau Chief Medical Officer | Feb 28, 2026 | Tax withholding | −369 | $107.88 | $39.81K | 17,644 |
| Patrick William Tuer EVP, Chief Operating Officer | Feb 28, 2026 | Tax withholding | −545 | $107.88 | $58.79K | 25,437 |
| Douglas E. Coltharp EVP & Chief Financial Officer | Feb 28, 2026 | Tax withholding | −776 | $107.88 | $83.71K | 69,377 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Feb 28, 2026 | Tax withholding | −416 | $107.88 | $44.88K | 83,947 |
| Andrew L. Price Chief Accounting Officer | Feb 28, 2026 | Tax withholding | −307 | $107.88 | $33.12K | 74,694 |
| Mark J. Tarr President & CEO, Director | Feb 28, 2026 | Tax withholding | −2,187 | $107.88 | $235.93K | 440,962 |
| Edmund Fay Sr. Vice Pres. and Treasurer | Feb 28, 2026 | Tax withholding | −280 | $107.88 | $30.21K | 101,262 |
| Patrick William Tuer EVP, Chief Operating Officer | Feb 23, 2026 | Tax withholding | −506 | $106.15 | $53.71K | 25,982 |
| Douglas E. Coltharp EVP & Chief Financial Officer | Feb 23, 2026 | Tax withholding | −14,818 | $106.15 | $1.57M | 70,153 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Feb 23, 2026 | Tax withholding | −6,990 | $106.15 | $741.99K | 84,363 |
| Mark J. Tarr President & CEO, Director | Feb 23, 2026 | Tax withholding | −2,488 | $106.15 | $264.10K | 443,149 |
| Elissa Joy Charbonneau Chief Medical Officer | Feb 23, 2026 | Tax withholding | −440 | $106.15 | $46.71K | 18,013 |
| Edmund Fay Sr. Vice Pres. and Treasurer | Feb 23, 2026 | Tax withholding | −380 | $106.15 | $40.34K | 101,542 |
| Andrew L. Price Chief Accounting Officer | Feb 23, 2026 | Tax withholding | −404 | $106.15 | $42.88K | 75,001 |
| John Patrick Darby EVP, Gen Counsel & Secretary | Feb 20, 2026 | Tax withholding | −328 | $106.55 | $34.95K | 91,353 |
| Patrick William Tuer EVP, Chief Operating Officer | Feb 20, 2026 | Tax withholding | −405 | $106.55 | $43.15K | 26,488 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Patrick Darby John Officer | Aug 31, 2026 | 4,858 | $588.26K | Aug 31, 2026 | Stock Option Exercise |
| Coltharp Douglas Officer | Aug 10, 2026 | 18,869 | $2.37M | Aug 10, 2026 | RSA Vesting |
| Patrick Darby John Officer | Aug 10, 2026 | 8,906 | $1.12M | Aug 10, 2026 | RSU Vesting |
| Tarr Mark Officer | Aug 10, 2026 | 173,148 | $21.72M | Aug 10, 2026 | Equity Plan |
| Edward Coltharp Douglas Officer | May 15, 2026 | 27,694 | $2.96M | May 15, 2026 | Stock Option Exercise |
| Tuer Patrick Officer | May 11, 2026 | 682 | $71.31K | May 11, 2026 | RSA Vesting |
| Tarr Mark Officer | Feb 11, 2026 | 150,000 | $16.74M | Feb 11, 2026 | RSA Vesting |
| Tuer Patrick Officer | Feb 10, 2026 | 2,804 | $301.76K | Feb 10, 2026 | RSU Vesting |
| Tuer Patrick Officer | Aug 27, 2025 | 1,020 | $126.06K | Aug 27, 2025 | RSU Vesting |
| Tarr Mark Officer | May 20, 2025 | 118,384 | $14.38M | May 20, 2025 | Stock Option Exercise |
| Edward Coltharp Douglas Officer | Apr 29, 2025 | 43,575 | $5.02M | Apr 29, 2025 | Stock Option Exercise |
| Patrick Darby John Officer | Apr 29, 2025 | 14,858 | $1.71M | Apr 29, 2025 | Stock Option Exercise |
| Coltharp Douglas Officer | Aug 13, 2024 | 12,260 | $1.06M | Aug 13, 2024 | Stock Option Exercise |
| John Chidsey Officer | May 22, 2024 | 29,500 | $2.52M | May 22, 2024 | Vesting of restricted stock unit award |
| Patrick Darby John Officer | May 6, 2024 | 14,543 | $1.22M | May 6, 2024 | stock option exercise |